Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 15;2022(60):111-116.
doi: 10.1093/jncimonographs/lgac017.

Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials

Affiliations

Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials

Grace E Mishkin et al. J Natl Cancer Inst Monogr. .

Abstract

Background: Older adults are a large and growing proportion of cancer cases in the United States, but concerns persist about whether older adults are adequately represented in the cancer clinical trials that test new options for treatment and cancer care.

Methods: This paper describes adult patient enrollments by age group to the National Cancer Institute's National Clinical Trials Network (NCTN) from 2016 to 2021, compares patient enrollment by age with the estimated incident cancer population across cancer types, and explores possible associations between patient age and patient race, ethnicity, and sex.

Results: This analysis found that patients aged 18 to 69 years were overrepresented in NCTN trials, whereas patients aged 70 years and older were underrepresented compared with the estimated incident cancer population. Underrepresentation of older patients was seen across cancer types. Older patients who enrolled to NCTN trials were more likely to be non-Hispanic White than the estimated incident cancer population.

Conclusions: Compared with earlier analyses, NCTN trials are enrolling greater proportions of older adults, primarily driven by higher enrollment among patients aged 65 to 74 years. There is still significant room for improvement, however, especially among patients aged 75 years and older. Additionally, patient demographics should not be viewed in isolation: older Hispanic patients, for instance, were particularly underrepresented among patients enrolled to NCTN trials. The intersection between trial enrollment and age, race, and ethnicity warrants further study so that more targeted enrollment enhancement efforts can be developed that enhance trial diversity across demographic groups.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of adult enrollments to the National Cancer Institute’s National Clinical Trials Network by age at enrollment and enrollment year.
Figure 2.
Figure 2.
Proportion of adult enrollments to the National Cancer Institute’s National Clinical Trials Network and estimated cancer incidence by age group, sex, race and ethnicity. All groups are mutually exclusive, limited to categories with at least 1000 enrollments in each subgroup. NHB = non-Hispanic Black; NHW = non-Hispanic White.

References

    1. Trimble EL, Carter CL, Cain D, et al. Representation of older patients in cancer treatment trials. Cancer. 1994;74(suppl 7):2208-2214. - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720-2726. - PubMed
    1. Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol. 2012;30(17):2036-2038. - PubMed
    1. Sedrak MS, Freedman RA, Cohen HJ, et al.; for the Cancer and Aging Research Group (CARG). Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78-92. - PMC - PubMed
    1. Mooney M. Older Patients in NCI-sponsored Clinical Treatment Trials. https://meetinglibrary.asco.org/record/68859/video. Published 2012. Accessed August 8, 2022.